Laurion Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,186	Closed	-$249K	–	327
2025 Q2	$249K	Buy	+3,186	New	+$238K	0.03%	309
2024 Q3	–	Sell	-8,753	Closed	-$809K	–	410
2024 Q2	$809K	Buy	+8,753	New	+$775K	0.03%	312
2022 Q4	–	Hold	0	–	–	–	473
2022 Q3	–	Hold	0	–	–	–	538
2022 Q2	–	Sell	-4,270	Closed	-$503K	–	559
2022 Q1	$503K	Buy	+4,270	New	+$479K	0.01%	302
2021 Q2	–	Sell	-50,000	Closed	-$4.18M	–	791
2021 Q1	$4.18M	Sell	50,000 -323,622	-87%	-$27.4M	0.06%	354
2020 Q4	$34.1M	Buy	+373,622	New	+$31M	1.04%	91
2020 Q1	–	Sell	-103,026	Closed	-$8.01M	–	880
2019 Q4	$8.01M	Buy	+103,026	New	+$8.04M	0.38%	251
2019 Q3	–	Sell	-29,481	Closed	-$1.81M	–	1112
2019 Q2	$1.81M	Buy	+29,481	New	+$1.78M	0.09%	434
2019 Q1	–	Sell	-118,047	Closed	-$6.03M	–	981
2018 Q4	$6.03M	Buy	118,047 +106,533	+925%	+$5.39M	0.29%	243
2018 Q3	$668K	Buy	+11,514	New	+$563K	0.02%	772
2016 Q4	–	Sell	-9,000	Closed	-$362K	–	1187
2016 Q3	$362K	Sell	9,000 -1,500	-14%	-$56.5K	0.01%	696
2016 Q2	$349K	Sell	10,500 -17,100	-62%	-$585K	0.02%	626
2016 Q1	$812K	Buy	+27,600	New	+$762K	0.07%	464